Emyria Company Update Presentation
Filed with ASX · · 24 pages · English
Summary by 6ix AI
Emyria Ltd has released a company update presentation detailing its progress and future plans in mental health treatments, particularly focusing on psychedelic-assisted therapies. The presentation highlights the establishment timelines for clinics and projected breakeven points for standalone clinics. Emyria aims to address significant gaps in mental healthcare by developing new treatments for conditions like PTSD and treatment-resistant depression.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Emyria
- TGA Update to Accelerate Empax Therapist Recruitment
- Emyria Activates First Victorian Empax Clinic
- March Quarter Investor Video Presentation
- Emyria Extends National Expansion into New South Wales
- March 2026 Quarterly Activities Report and Appendix 4C
Later from Emyria
- Emyria Confirms NSW Workforce Ahead of Clinic Opening
- Emyria Depression Program Shows Positive Results
- June 2026 Quarterly Activities Report and Appendix 4C
- Emyria Unlocks Treatment Capacity
- Appendix 4E & Annual Financial Report Year End 30 June 2026
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria